HomeInsightsStock Comparison

Pharmaids Pharmaceuticals Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Pharmaids Pharmaceuticals Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Last Updated on: Jul 01, 2025

Key Highlights

  • The Latest Trading Price of Pharmaids Pharmaceuticals Ltd is ₹ 57 as of 01 Jul 11:04.
  • The P/E Ratio of Pharmaids Pharmaceuticals Ltd changed from 89.4 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 67.1 on March 2022 to 49.4 on March 2021 . This represents a CAGR of -5.94% over 5 years.
  • The Market Cap of Pharmaids Pharmaceuticals Ltd changed from ₹ 12.9 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 219491 crore on March 2022 to ₹ 143384 crore on March 2021 . This represents a CAGR of -8.16% over 5 years.
  • The revenue of Pharmaids Pharmaceuticals Ltd for the Mar '25 is ₹ 4.9 crore as compare to the Dec '24 revenue of ₹ 4.72 crore. This represent the growth of 3.81% The revenue of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 13571 crore as compare to the Dec '24 revenue of ₹ 14141 crore. This represent the decline of -4.03%.
  • The ebitda of Pharmaids Pharmaceuticals Ltd for the Mar '25 is ₹ -3.77 crore as compare to the Dec '24 ebitda of ₹ -2.89 crore. This represent the growth of 30.45% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 3967 crore as compare to the Dec '24 ebitda of ₹ 4158 crore. This represent the decline of -4.6%.
  • The net profit of Pharmaids Pharmaceuticals Ltd changed from ₹ -1.3 crore to ₹ -4.8 crore over 8 quarters. This represents a CAGR of 92.15% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2160 crore over 8 quarters. This represents a CAGR of 3.60% .
  • The Dividend Payout of Pharmaids Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Pharmaids Pharmaceuticals Ltd

  • Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc.
  • The technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygiene standards.
  • The Company is primarily engaged in business of manufacturing of Generics, Bulk Drugs in various forms like tablets, capsules, liquids and powders etc., in allopathic and herbal Ayurvedic and Natural drug formulation. Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019.
  • Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019.

About Sun Pharmaceuticals Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Pharmaids Pharmaceuticals Ltd News Hub

News

Pharmaids Pharmaceuticals to discuss results

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

21 May 2025 13:01

News

Pharmaids Pharmaceuticals to table results

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

08 Feb 2025 15:39

News

Pharmaids Pharmaceuticals to announce Quarterly Result

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

08 Nov 2024 12:31

News

Pharmaids Pharmaceuticals AGM scheduled

Pharmaids Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the comp...

Read more

03 Sep 2024 17:10

News

Pharmaids Pharmaceuticals to convene board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

21 Aug 2024 10:05

News

Pharmaids Pharmaceuticals schedules board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

07 Aug 2024 13:55

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharma updates on US FDA inspection

Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing ...

Read more

14 Jun 2025 12:11

News

Board of Sun Pharmaceutical Industries appoints director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has approved...

Read more

23 May 2025 11:13

News

Sun Pharmaceutical Industries announces cessation of director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has noted th...

Read more

23 May 2025 11:14

News

Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr

Profit before tax (PBT) jumped 15.6% YoY to Rs 3,254.35 crore in Q4 FY25. During the quart...

Read more

23 May 2025 13:48

News

Sun Pharmaceuticals Industries AGM scheduled

Sun Pharmaceuticals Industries announced that the 33th Annual General Meeting(AGM) of the ...

Read more

23 May 2025 15:37

News

Board of Sun Pharmaceuticals Industries recommends final dividend

Sun Pharmaceuticals Industries announced that the Board of Directors of the Company at its...

Read more

22 May 2025 20:47

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Pharmaids Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Pharmaids Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Pharmaids Pharmaceuticals Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Pharmaids Pharmaceuticals Ltd is 202 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 402,320 Cr

What are the key factors driving the stock performance of Pharmaids Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Pharmaids Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Pharmaids Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd?

As of July 1, 2025, the Pharmaids Pharmaceuticals Ltd stock price is INR ₹57.35. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1676.8.

How do dividend payouts of Pharmaids Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Pharmaids Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions